Silence Therapeutics (SLN) Receivables - Net (2019 - 2025)
Silence Therapeutics recorded quarterly Receivables - Net of $28000.0 in Q3 2025, down 67.06% quarter-over-quarter from $85000.0 in Q2 2025, and down 92.52% year-over-year from $374198.4 in Q3 2024.
Silence Therapeutics' Receivables - Net history runs 7 years deep, the most recent figure standing at $28000.0 for Q3 2025.
- In Q3 2025, Receivables - Net fell 92.52% year-over-year to $28000.0; the TTM figure through Sep 2025 stood at $28000.0 (down 92.52% YoY), while the FY2024 annual figure was $972000.0, up 235.17% from the prior year.
- Receivables - Net came in at $28000.0 for Q3 2025 at Silence Therapeutics, down from $85000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $15.4 million in Q2 2023 to a low of $28000.0 in Q3 2025.
- A 5-year average of $2.5 million and a median of $612205.0 in 2021 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net jumped 496.74% in 2022 and sank 99.6% in 2025, its largest moves.
- Silence Therapeutics' Receivables - Net stood at $446191.5 in 2021, then soared by 140.53% to $1.1 million in 2022, then slumped by 73.63% to $282982.6 in 2023, then soared by 243.48% to $972000.0 in 2024, then slumped by 97.12% to $28000.0 in 2025.
- According to Business Quant data, Receivables - Net over the past three periods registered $28000.0, $85000.0, and $41000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 28,000.00 |
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 972,000.00 |
| Dec 31, 2024 | 972,000.00 |
| Sep 30, 2024 | 374,198.45 |
| Sep 30, 2024 | 374,198.45 |
| Jun 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 2.13 Mn |
| Mar 31, 2024 | 10.33 Mn |
| Mar 31, 2024 | 10.33 Mn |
| Dec 31, 2023 | 282,982.63 |
| Dec 31, 2023 | 282,982.63 |
| Sep 30, 2023 | 585,208.37 |
| Sep 30, 2023 | 585,208.37 |
| Jun 30, 2023 | 15.42 Mn |
| Jun 30, 2023 | 15.42 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Mar 31, 2023 | 2.06 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 153,211.28 |
| Sep 30, 2022 | 153,211.28 |
| Jun 30, 2022 | 3.65 Mn |
| Jun 30, 2022 | 3.65 Mn |
| Mar 31, 2022 | 3.45 Mn |
| Mar 31, 2022 | 3.45 Mn |
| Dec 31, 2021 | 446,191.51 |
| Dec 31, 2021 | 446,191.51 |
| Jun 30, 2021 | 612,204.98 |
| Jun 30, 2021 | 612,204.98 |
| Dec 31, 2020 | 38.70 Mn |
| Dec 31, 2020 | 38.70 Mn |
| Jun 30, 2020 | 40.89 Mn |
| Jun 30, 2020 | 40.89 Mn |
| Dec 31, 2019 | 5,142.90 |
| Dec 31, 2019 | 5,142.90 |